We are looking forward to a presentation by professor Carl-Henrik Heldin, Uppsala University, Department of Medical Biochemistry and Microbiology:
“Can insights into the signaling mechanisms of TGFbeta improve tumor treatment?”
The research interest of C-H. Heldin is related to the mechanisms of signal transduction by growth regulatory factors, as well as their normal function and role in disease. In particular, platelet-derived growth factor (PDGF), a major mitogen for connective tissue cells, and transforming growth factor β (TGF β), which inhibits the growth of most cell types, are studied. An important goal is to explore the possible clinical utility of signal transduction antagonists.
Read more about Carl-Henrik Heldin research group.
